Association of metabolic syndrome with development of new-onset diabetes after transplantation

Transplantation

Volumn 90, Issue 8, 2010, Pages 861-866

  Bayer, Nathaniel D ^a   Cochetti, Philip T ^a   Anil Kumar, Mysore S ^b   Teal, Valerie ^a   Huan, Yonghong ^c   Doria, Cataldo ^c   Bloom, Roy D ^a   Rosas, Sylvia E ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Metabolic syndrome; NODAT; Renal transplant

Indexed keywords

GLUCOSE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEW ONSET DIABETES AFTER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; DIET RESTRICTION; IMMUNOLOGY; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; REGRESSION ANALYSIS;

BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYCYSTIC KIDNEY DISEASES; PREVALENCE; REGRESSION ANALYSIS; TACROLIMUS;

EID: 78349274322     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f1543c     Document Type: Article

References (48)

1. Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 2002; 25: 583.
2. Miles AM, Sumrani N, Horowitz R, et al. Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380.
3. Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440.
4. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
5. Fernandez-Fresnedo G, Escallada R, de Francisco AL, et al. Posttrans-plant diabetes is a cardiovascular risk factor in renal transplant patients. Transplant Proc 2003; 35: 700. (Pubitemid 36338120)
6. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603.
7. Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588.
8. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496.
9. Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 2005; 79: 438.
10. Pham PT, Danovitch GM, Pham PC. The medical management of the renal transplant recipient. In: Johnson RJ, Feehally J, eds. Comprehensive clinical nephrology. Philadelphia, Mosby 2007, pp 1085.
11. Sumrani NB, Delaney V, Ding ZK, et al. Diabetes mellitus after renal transplantation in the cyclosporine era-An analysis of risk factors. Transplantation 1991; 51: 343.
12. Bloom RD, Rao V, Weng F, et al. Association of hepatitis C with post-transplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002; 13: 1374.
13. Hjelmesaeth J, Muller F, Jenssen T, et al. Is there a link between cyto-megalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant 2005; 20: 2311.
14. van der Werf N, Kroese FG, Rozing J, et al. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 2007; 23: 169.
15. Hamer RA, Chow CL, Ong AC, et al. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007; 83: 36.
16. Ducloux D, Motte G, Vautrin P, et al. Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol Dial Transplant 1999; 14: 1244.
17. de Mattos AM, Olyaei AJ, Prather JC, et al. Autosomal-dominant poly-cystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 2005; 67: 714.
18. Reisaeter AV, Hartmann A. Risk factors and incidence of posttrans-plant diabetes mellitus. Transplant Proc 2001; 33(5A suppl): 8S.
19. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414.
20. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens 2008; 26: 1602.
21. Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: Current state of the evidence. Diabetes Care 2008; 31: 1898.
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143.
23. Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160.
24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007; 30(suppl 1): S42.
25. Young DO, Lund RJ, Haynatzki G, et al. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial Int 2007; 11: 86.
26. Lea J, Cheek D, Thornley-Brown D, et al. Metabolic syndrome, pro-teinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 2008; 51: 732.
27. Porrini E, Delgado P, Bigo C, et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 2006; 48: 134.
28. Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes melli-tus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732.
29. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003; 75(10 suppl): SS3.
30. Abbott KC, Lentine KL, Bucci JR, et al. Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol 2004; 15: 3166.
31. Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008; 371: 1927.
32. Wang JJ, Hu G, Miettinen ME, et al. The metabolic syndrome and incident diabetes: Assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. Horm Metab Res 2004; 36: 708.
33. Cameron AJ, Magliano DJ, Zimmet PZ, et al. The metabolic syndrome asatool for predicting future diabetes: The AusDiab study.J Intern Med 2008; 264: 177.
34. Wilson PW, D'Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066.
35. Fabrizi F, Lampertico P, Lunghi G, et al. Review article: Hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation. Aliment Pharmacol Ther 2005; 21: 623.
36. Delgado-Borrego A, Casson D, Schoenfeld D, et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004; 77: 703.
37. Aytug S, Reich D, Sapiro LE, et al. Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38: 1384.
38. Masini M, Campani D, Boggi U, et al. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care 2005; 28: 940.
39. Kawaguchi T, Yoshida T, Harada M, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165: 1499.
40. First MR, Gerber DA, Hariharan S, et al. Posttransplant diabetes mel-litus in kidney allograft recipients: Incidence, risk factors, and management. Transplantation 2002; 73: 379.
41. Rike AH, Mogilishetty G, Alloway RR, et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: Comparison of early steroid withdrawal and chronic steroids. Clin Transplant 2008; 22: 229.
42. Crutchlow MF, Bloom RD. Transplant-associated hyperglycemia: A new look at an old problem. Clin J Am Soc Nephrol 2007; 2: 343.
43. Burroughs TE, Swindle J, Takemoto S, et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 2007; 83: 1027.
44. Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004; 4: 583.
45. Armstrong KA, Campbell SB, Hawley CM, et al. Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 2005; 5: 2710.
46. Vareesangthip K, Tong P, Wilkinson R, et al. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997; 52: 503.
47. Vareesangthip K, Thomas TH, Wilkinson R. Abnormal effect of thiol groups on erythrocyte Na/Li countertransport kinetics in adult poly-cystic kidney disease. Nephrol Dial Transplant 1995; 10: 2219.
48. Pietrzak-Nowacka M, Safranow K, Byra E, et al. Metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease. Kidney Blood Press Res 2009; 32: 405.